Suppr超能文献

睑痉挛和半面痉挛。

Blepharospasm and Hemifacial Spasm.

作者信息

Boghen DR, Lesser RL

机构信息

Centre Hospitalier de l'Universite de Montreal, 3840 St-Urbain Street, Montreal, Quebec, H2W 1T8, Canada.

出版信息

Curr Treat Options Neurol. 2000 Sep;2(5):393-400. doi: 10.1007/s11940-000-0037-7.

Abstract

The main objective in the treatment of blepharospasm is to decrease or cease the unwanted, repeated forced closure of the eyelids. This is best achieved by the use of botulinum toxin. In a minority of patients, botulinum toxin is either ineffective or poorly tolerated. In this group of patients, a trial with oral medication in the following order is warranted: trihexyphenidyl, baclofen, clonazepam, and tetrabenazine. Before going to the next medication, each of these drugs should be administered at the highest tolerated dosage for a period of 1 or 2 months. If, as often happens, all pharmacologic treatment attempts fail, and the patient is too disabled to remain untreated, he or she can be referred to an experienced plastic surgeon for a myectomy of the eyelid protractors. For treatment of apraxia of eyelid opening, botulinum toxin should be administered as the first treatment. If this fails, and vision is significantly impaired, the patient may be referred to a plastic surgeon for a frontalis suspension of the eyelid. Treatments of hemifacial spasm are aimed at decreasing or ending the annoying twitches of one side of the face. In this disorder, interference with vision is not a problem unless the contralateral eye is amblyopic. Despite isolated reports of spasm relief by drugs such as carbamazepine, oral medication is unlikely to be helpful. Botulinum toxin is the preferred treatment in hemifacial spasm patients. In some patients, relief from spasms can only be obtained at the cost of an ipsilateral upper lip droop of varying severity. Patients who are dissatisfied with the results of treatment with botulinum toxin, and are not willing to tolerate their condition, can be referred to an experienced neurosurgeon for microvascular decompression of the facial nerve. Pending success of ongoing attempts to reduce adverse effects, we believe that doxorubicin chemomyectomy, a recent treatment that has been used for both facial spasm and blepharospasm, is best administered in a research setting.

摘要

眼睑痉挛治疗的主要目标是减少或停止不必要的、反复的眼睑强制闭合。使用肉毒杆菌毒素能最好地实现这一目标。在少数患者中,肉毒杆菌毒素要么无效,要么耐受性差。对于这类患者,有必要按以下顺序进行口服药物试验:苯海索、巴氯芬、氯硝西泮和丁苯那嗪。在使用下一种药物之前,每种药物都应以最高耐受剂量服用1至2个月。如果像常见的情况那样,所有药物治疗尝试均失败,且患者因病情严重而无法不接受治疗,可将其转介给经验丰富的整形外科医生进行眼睑牵开肌切除术。对于眼睑开合失用症的治疗,应首先使用肉毒杆菌毒素。如果治疗失败,且视力明显受损,可将患者转介给整形外科医生进行眼睑额肌悬吊术。面肌痉挛的治疗旨在减少或消除一侧面部令人烦恼的抽搐。在这种疾病中,除非对侧眼睛弱视,否则不会出现视力干扰问题。尽管有关于卡马西平等药物缓解痉挛的个别报道,但口服药物不太可能有帮助。肉毒杆菌毒素是面肌痉挛患者的首选治疗方法。在一些患者中,只能以不同程度的同侧上唇下垂为代价来缓解痉挛。对肉毒杆菌毒素治疗结果不满意且不愿忍受病情的患者,可转介给经验丰富的神经外科医生进行面神经微血管减压术。在降低不良反应的持续尝试取得成功之前,我们认为阿霉素化学性肌切除术(一种最近用于治疗面部痉挛和眼睑痉挛的疗法)最好在研究环境中使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验